Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Calcinosis, Scleroderma, Abnormality of chromosome stability, and Sclerodactyly and 3 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | Telangiectasia |
Biomarker and diagnostic research for scleroderma, familial progressive has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily industry-sponsored.
143 publications have been identified in PubMed for scleroderma, familial progressive. Research spans Review / Meta-Analysis (30%), Epidemiology / Natural History (28%), and Case Report / Case Series (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 38 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:28 PM UTC
Online Mendelian Inheritance in Man
Disease patterns and progression |
36 |
28% |
Patient case studies | 24 | 19% |
Laboratory research | 24 | 19% |
Testing and diagnosis research | 2 | 2% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
New treatment approaches | 1 | 1% |
Frazier W MD, MPH (2026). [PMID: 42101599](https://pubmed.ncbi.nlm.nih.gov/42101599/). *Am Fam Physician*. [Review / Meta-Analysis]
Padilla CM (2026). [PMID: 40771159](https://pubmed.ncbi.nlm.nih.gov/40771159/). *Arthritis Care Res (Hoboken)*. [Diagnostic / Biomarker]
Rodriguez-Martin I (2026). [PMID: 41999721](https://pubmed.ncbi.nlm.nih.gov/41999721/). *Lancet Rheumatol*. [Epidemiology / Natural History]
Pan J (2026). [PMID: 42136825](https://pubmed.ncbi.nlm.nih.gov/42136825/). *Open Life Sci*. [Review / Meta-Analysis]
Xiao Y (2026). [PMID: 41866288](https://pubmed.ncbi.nlm.nih.gov/41866288/). *Ann Rheum Dis*. [Basic Science / Preclinical]
Giovengo M (2026). [PMID: 41892626](https://pubmed.ncbi.nlm.nih.gov/41892626/). *Brain Sci*. [Review / Meta-Analysis]
Martínez-López J (2026). [PMID: 41236837](https://pubmed.ncbi.nlm.nih.gov/41236837/). *Arthritis Rheumatol*. [Epidemiology / Natural History]
Aiton E (2026). [PMID: 41851855](https://pubmed.ncbi.nlm.nih.gov/41851855/). *BMC Med*. [Epidemiology / Natural History]
Fontes-Dantas FL (2026). [PMID: 41219597](https://pubmed.ncbi.nlm.nih.gov/41219597/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Adigun R (2026). [PMID: 28613625](https://pubmed.ncbi.nlm.nih.gov/28613625/). *Unknown Journal*. [Review / Meta-Analysis]
AI-curated news mentioning scleroderma, familial progressive
Updated Sep 7, 2026
A recent study highlights the complexities of managing scleroderma renal crisis and associated cardiac complications in a young patient with mixed connective tissue disease (MCTD). The case emphasizes the need for further research into the implications of anti-U3 RNP and anti-RNA polymerase III antibodies.
Recent research highlights the occurrence of scleroderma renal crisis in patients with mixed connective tissue disease, providing new insights into this rare complication. Understanding this association may improve clinical management and patient outcomes.
A new study highlights the cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis. This research provides insights into the pathophysiology of the disease, which may inform future therapeutic strategies.